Changing Paradigms in Breast Cancer Diagnosis and Treatment, an Issue of Surgical Oncology Clinics of North America

Changing Paradigms in Breast Cancer Diagnosis and Treatment, an Issue of Surgical Oncology Clinics of North America

  • Kelly K. Hunt
Publisher:ElsevierISBN 13: 9780323566599ISBN 10: 0323566596

Paperback & Hardcover deals ―

Amazon IndiaGOFlipkart GOSnapdealGOSapnaOnlineGOJain Book AgencyGOBooks Wagon₹8,703Book ChorGOCrosswordGODC BooksGO

e-book & Audiobook deals ―

Amazon India GOGoogle Play Books GOAudible GO

* Price may vary from time to time.

* GO = We're not able to fetch the price (please check manually visiting the website).

Know about the book -

Changing Paradigms in Breast Cancer Diagnosis and Treatment, an Issue of Surgical Oncology Clinics of North America is written by Kelly K. Hunt and published by Elsevier. It's available with International Standard Book Number or ISBN identification 0323566596 (ISBN 10) and 9780323566599 (ISBN 13).

This issue of Surgical Oncology Clinics of North America, guest edited by Dr. Kelly Hunt, is devoted to Changing Paradigms in Breast Cancer Diagnosis and Treatment. Dr. Hunt has assembled expert authors to review the following topics: Tomosynthesis in breast cancer imaging: how does it fit into preoperative evaluation and surveillance?; Lobular breast cancer: different disease, different algorithms?; Hypofractionated radiation therapy in breast conserving therapy; Oncoplastic breast reconstruction: should all patients be considered?; Neoadjuvant endocrine therapy: who benefits most?; Breast cancer disparities: how can we leverage genomics to improve outcomes?; Anatomy and breast cancer staging: is it still relevant?; When does atypical ductal hyperplasia require surgical intervention?; Surgical intervention for lymphedema; Are there alternative strategies in the local management of DCIS?; Genetic testing and genetic counseling: what is standard of care?; Molecular subtypes and local-regional control of breast cancer; Intraoperative margin assessment in breast cancer management; Triple negative breast cancer: who should receive neoadjuvant chemotherapy?; and more!